Cardiovascular disease and risk factors in adults with hypopituitarism (Q33643486)

28 July 2017

1 reference

title

Cardiovascular disease and risk factors in adults with hypopituitarism (English)

1 reference

28 July 2017

main subject

cardiovascular disease

1 reference

Beshyah SA

1

1 reference

28 July 2017

Johnston DG

series ordinal

2

1 reference

28 July 2017

publication date

1 January 1999

1 reference

28 July 2017

published in

Clinical Endocrinology

1 reference

28 July 2017

volume

50

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-15

1 reference

Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Beta-cell function in hypopituitary adults before and during growth hormone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The restoration of cardiac hypertrophy and blood pressure in hypophysectomized rats by large doses of lyophilized anterior pituitary and growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

AN EVALUATION OF SEVENTY-FIVE PATIENTS WITH HYPOPITUITARISM BEGINNING IN CHILDHOOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Increased cerebrovascular mortality in patients with hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The growth hormone deficiency syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Effect of growth hormone on carbohydrate and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Cardiovascular mortality among pituitary insufficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Peripheral glucose metabolism in human hyperprolactinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

21 January 2018

Importance of obesity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Hormonal and metabolic rhythms in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Beneficial effects of growth hormone treatment in GH-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Relation of body fat distribution to metabolic complications of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Elevated fibrinogen levels decrease following treatment of acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nerv

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Arterial wall compliance in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Cardiac size and function in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Heart size and function in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Glucose and lipid homeostasis in the absence of human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Studies of hyperlipidemia in the HGH-deficient state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Vascular disease in the chronic HGH-deficient state

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The assessment of glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Obesity associated insulin resistance occurs in hypopituitary subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Decreased High Density Lipoprotein Cholesterol in Hypopituitarism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Body composition in growth hormone deficient adults over the age of 60 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

Serum cholesterol and triglycerides in children with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00682.X

10.1046/J.1365-2265.1999.00682.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference